crta
Hrvatska znanstvena Sekcija img
bibliografija
3 gif
 Naslovna
 O projektu
 FAQ
 Kontakt
4 gif
Pregledavanje radova
Jednostavno pretraživanje
Napredno pretraživanje
Skupni podaci
Upis novih radova
Upute
Ispravci prijavljenih radova
Ostale bibliografije
Slični projekti
 Bibliografske baze podataka

Pregled bibliografske jedinice broj: 4727

Časopis

Autori: Pavelić, Krešimir; Hrašćan, Reno; Čabrijan, Tomislav; Križanac, Šimun; Eljuga, Damir; Pavelić, Ljubomir; Karapandža, Nikola; Kusić, Zvonimir; Spaventi, Šime; Pavelić, Jasminka
Naslov: Point mutation of tumor suppressor gene p53 in two highly malignant metastatic insulinomas
Izvornik: Tumor Diagnostik und Therapie (0722-219X) 18 (1997), 4; 102-106
Vrsta rada: članak
Ključne riječi: malignant insulinoma; point mutations; p53 gene
Sažetak:
Background: The objective of the study was to define the molecular alterations of the tumor suppressor p53 gene that are associated with tumors of the endocrine pancreas: benign and malignant pancreatic insulinomas. Materials and Methods: The expression of the mutant p53 protein was evaluated immunohistochemically on formalin-fixed paraffin-embedded tumor sections (29 benign insulinoma tissues, 9 malignant insulinomas, 2 B-cell hyperplasia specimens, 3 normal pancreatic tissue samples) using monoclonal (Ab-6) antibodies for p53 proteins. Point mutations of the p53 gene were defined by direct sequencing of amplified DNA (asymmetric PCR, exons 4-9) obtained from one B-cell hyperplasia tissue, 5 benign insulinomas and 5 malignant insulinomas. Results: All of the normal pancreatic and B-cell hyperplasia samples as well as most of the benign insulinoma tissues (24 out of 29 samples) were negative for the mutated p53 protein. In malignant insulinomas an overexpression of the p53 protein was found (in 6 out of 9 samples). Point mutation (single base substitution) was detected in two out of five malignant insulinomas. The first tumor harbored a point mutation at codon 151 (CCC->TCC), while the second tumor harbored a mutation at codon 248 (CGG->GGG). Both patients survived 6 and 8 months respectively, after surgery and chemotherapy. No p53 mutations were identified in 5 benign insulinomas and one hyperplasia of the endocrine pancreas. Conclusions: Our results suggest a link between p53 gene alterations and the malignant stage of pancreatic insulinomas. Based upon these results, we have concluded that, in some rare cases, point mutation of the p53 tumor-suppressor gene may play a role in the development of malignant metastatic insulinomas. ŠReferences: 16Ć
Projekt / tema: 00981103, 00981104, 101751, 134005
Izvorni jezik: ENG
Rad je indeksiran u
bazama podataka:
Current Contents Connect (CCC)
Scopus
SCI-EXP, SSCI i/ili A&HCI
Science Citation Index Expanded (SCI-EXP) (sastavni dio Web of Science Core Collectiona)
Kategorija: Znanstveni
Znanstvena područja:
Temeljne medicinske znanosti,Kliničke medicinske znanosti
URL cjelovitog teksta:
Google Scholar: Point mutation of tumor suppressor gene p53 in two highly malignant metastatic insulinomas



  Verzija za printanje   za tiskati


upomoc
foot_4